Cardiology Edition

Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Cardiology News

Palpitations Predict Future Atrial Fibrillation

May 21, 2012

Palpitations, hypertension, and body mass index (BMI) are predictive of future atrial fibrillation (AF) in both men and women.

Short-Term Smoke Exposure Impairs Endothelial Function

May 18, 2012

Short-term exposure to low levels of secondhand smoke (SHS) results in a concentration-dependent decrease in endothelial function.

Teva, Mylan, Dr. Reddy's Launch Clopidogrel Tablets

May 18, 2012

Teva Pharmaceuticals has announced the introduction and availability of Clopidogrel Tablets, an AB rated and bioequivalent product to Plavix Tablets (Bristol-Myers Squibb and Sanofi Aventis). Clopidogrel Tablets 75mg are available from Teva in 30, 90, and 500 count bottles.

Recurrent HTN Seen for Half of Women With HTN in Pregnancy

May 18, 2012

About half of women who experience a hypertensive disorder of pregnancy and late-preterm delivery develop a hypertensive disorder in a subsequent pregnancy, although few have delivery before 37 weeks in the subsequent pregnancy.

DUTOPROL

5/21/2012

AstraZeneca Pharmaceuticals

Pharmacological Class: Cardioselective β₁-blocker + diuretic.

Active Ingredient(s): Metoprolol succinate extended-release, hydrochlorothiazide; 25/12.5mg, 50/12.5mg, 100/12.5mg; tablets.

Indication: Hypertension.

Daily Cardiovascular News

Conference News

Round-up

more >

Cardiology Courses on mycme.com

Risk Stratification, Treatment and Stroke Reduction in Atrial Fibrillation

1.00/ AMA PRA Category 1 Credit(s)^TM

Cardioembolic Stroke in Patients with Atrial Fibrillation & Similar Conditions

1.00/ AMA PRA Category 1 Credit(s)^TM
1.00/ CE for Nurses
1.00/ CE for Pharmacists

Visit mycme.com

Clinical Charts

Combination Treatments for Hypertension Chart

Angiotensin-Converting Enzyme (ACE) Inhibitors for Hypertension

Angiotensin II Receptor Blocker (ARB) for Hypertension

This new, complimentary webcast series, presented by the Johns Hopkins University School of Medicine, is designed to help clinicians improve their ability to diagnose, manage, and treat cardiovascular and cardiometabolic disorders.

Click here for a full listing of activities.